A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
SurvivorNet on MSN
Diagnosing muscle-invasive bladder cancer: The initial work-up
When a doctor suspects bladder cancer, they will order a series of tests which may include urine tests (urinalysis or urine ...
A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
A simple and cost-effective urine test could improve early detection and management of bladder cancer, according to a brief issued by the International Agency for Research on Cancer (IARC). This test ...
A urine test that detects proteins given off by malignant growths can identify bladder cancer faster and perhaps reduce the use of more invasive procedures, researchers said Tuesday. The $30 test that ...
Researchers have developed a test for urine, gathered during a routine procedure, to detect DNA mutations identified with urothelial cancers. Researchers at The Johns Hopkins Kimmel Cancer Center have ...
June 28 (UPI) --For patients with bladder cancer, a simple test can cut down on care costs, overtreatment and side effects, according to a study. Georgetown-led investigators said their test ...
Hosted on MSN
Simple urine test developed to screen bladder cancer
Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed ...
Add Yahoo as a preferred source to see more of our stories on Google. A range of other assessments besides the bladder pressure test work just as well in guiding treatment of female incontinence, ...
In a new study, researchers found that cystoscopy, the standard for screening for recurrence of early-stage bladder cancer, is a cost-effective method of detecting tumors. Adding other tests to ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) announced today the publication of new data demonstrating that the company’s Decipher Bladder genomic classifier accurately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results